Related Experiment Video
Updated: Aug 24, 2026

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
Published on: June 2, 2019
Has anything changed in multivessel coronary artery revascularization in diabetes since BARI?
Akhil Kapur1, Davide Bartolini, Kevin J Beatt
1Department of Cardiology, Hammersmith Hospital, National Heart and Lung Institute, Imperial College School of Medicine, London, UK.
Insights
Diabetic patients face higher coronary disease risks, necessitating revascularization. Limited data compares surgery and angioplasty, though surgery may be superior for multivessel disease.
Area of Science:
- Cardiology
- Diabetology
- Vascular Surgery
Background:
- Diabetic patients exhibit increased coronary heart disease (CHD) risk due to hypertension, hyperlipidemia, insulin resistance, hyperinsulinemia, and hyperglycemia.
- These factors elevate the need for coronary revascularization procedures in diabetic individuals.
- Current evidence comparing surgical revascularization and angioplasty in diabetic patients is limited.
Purpose of the Study:
- To discuss the elevated risks associated with coronary disease in diabetic patients.
- To review existing randomized data comparing coronary artery bypass grafting (CABG) surgery and angioplasty in this population.
- To outline recent advancements in angioplasty techniques since the Bypass Angioplasty Revascularization Investigation (BARI) trial.
Main Methods:
- Review of existing literature and clinical trial data, focusing on diabetic patients undergoing revascularization.
- Analysis of sub-studies, particularly the BARI trial, comparing surgical and percutaneous coronary intervention (PCI) outcomes.
- Discussion of contemporary angioplasty developments and their implications for diabetic patients.
Main Results:
- Diabetic patients present with a higher frequency of CHD risk factors and specific metabolic derangements.
- The BARI trial sub-analysis suggested surgical revascularization may be superior for diabetic patients with multivessel coronary artery disease.
- Despite BARI findings, multivessel angioplasty has seen increased use in diabetic patients in Europe.
Conclusions:
- Diabetic patients represent a high-risk population for coronary disease requiring careful consideration of revascularization strategies.
- While surgery showed potential superiority in older trials for multivessel disease, advances in angioplasty warrant ongoing evaluation.
- Further research is needed to define optimal revascularization strategies for diabetic patients in the current therapeutic landscape.
Abstract:
Diabetic patients have an increased risk of coronary disease partly due to a higher frequency of associated risk factors including hypertension and hyperlipidemia but also from specific risks largely resulting from insulin resistance, hyperinsulinemia and hyperglycemia. This has resulted in a greater need for revascularization. Despite this there are few randomized data comparing surgery and angioplasty in patients with diabetes. The evidence to define the best operative strategy is limited, mainly confined to a subanalysis of the BARI trial suggesting the superiority of surgery in patients with multivessel disease. However there has been in Europe a wide increase in multivessel angioplasty, even in diabetic patients. This article discusses the higher risk of patients with diabetes, the data comparing surgery and angioplasty and outlines the advances in angioplasty since BARI.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Diabetic Retinopathy
Peripheral Artery Disease III: Interprofessional Care
Complications of Diabetes Mellitus
Diabetic Nephropathy